Crossmark

One-Step Biallelic and Scarless Correction of a β-Thalassemia Mutation in Patient-Specific iPSCs without Drug Selection

Crossref DOI link: https://doi.org/10.1016/j.omtn.2016.11.010

Published Print: 2017-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Liu, Yali

Yang, Yi

Kang, Xiangjin

Lin, Bin

Yu, Qian

Song, Bing

Gao, Ge

Chen, Yaoyong

Sun, Xiaofang

Li, Xiaoping

Bu, Lei

Fan, Yong
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81570101)

National Natural Science Foundation of China (81370766)

National Natural Science Foundation of China (31601187)

National Natural Science Foundation of China (81671121)

National Natural Science Foundation of China (81401254)

Bureau of Education of Guangzhou Municipality (201505011111498)

New York University

Science and Technology Planning Project of Guangdong Province (2016A020216023)

Science and Technology Planning Project of Guangdong Province (2014TQ01R683)

Science and Technology Planning Project of Guangdong Province (2015A030310119)

Science and Technology Planning Project of Guangdong Province (2014A02011029)
License Information

Text and Data Mining valid from 2017-03-01

Text and Data Mining valid from 2017-03-01

Version of Record valid from 2016-12-07
More Information

This article is maintained by: Elsevier

Article Title: One-Step Biallelic and Scarless Correction of a β-Thalassemia Mutation in Patient-Specific iPSCs without Drug Selection

Journal Title: Molecular Therapy - Nucleic Acids

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.omtn.2016.11.010

Content Type: article

Copyright: © 2016 The Authors.